Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3255 | 1951 | 41.0 | 88% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1004 | 9883 | POSTCONDITIONING//ISCHEMIC PRECONDITIONING//NICORANDIL |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | KIR62 | Author keyword | 96 | 60% | 5% | 106 |
2 | ATP SENSITIVE K CHANNEL | Author keyword | 68 | 43% | 6% | 121 |
3 | SUR2A | Author keyword | 67 | 89% | 2% | 31 |
4 | SULFONYLUREA RECEPTOR | Author keyword | 66 | 57% | 4% | 78 |
5 | ATP SENSITIVE POTASSIUM CHANNEL | Author keyword | 49 | 38% | 5% | 105 |
6 | K ATP CHANNEL | Author keyword | 47 | 28% | 7% | 144 |
7 | SULPHONYLUREA RECEPTOR | Author keyword | 36 | 65% | 2% | 34 |
8 | ATP SENSITIVE K CHANNELS | Author keyword | 22 | 33% | 3% | 55 |
9 | GLIBENCLAMIDE | Author keyword | 21 | 13% | 8% | 158 |
10 | PHARMACODYNAM THER EUT | Address | 21 | 75% | 1% | 15 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | KIR62 | 96 | 60% | 5% | 106 | Search KIR62 | Search KIR62 |
2 | ATP SENSITIVE K CHANNEL | 68 | 43% | 6% | 121 | Search ATP+SENSITIVE+K+CHANNEL | Search ATP+SENSITIVE+K+CHANNEL |
3 | SUR2A | 67 | 89% | 2% | 31 | Search SUR2A | Search SUR2A |
4 | SULFONYLUREA RECEPTOR | 66 | 57% | 4% | 78 | Search SULFONYLUREA+RECEPTOR | Search SULFONYLUREA+RECEPTOR |
5 | ATP SENSITIVE POTASSIUM CHANNEL | 49 | 38% | 5% | 105 | Search ATP+SENSITIVE+POTASSIUM+CHANNEL | Search ATP+SENSITIVE+POTASSIUM+CHANNEL |
6 | K ATP CHANNEL | 47 | 28% | 7% | 144 | Search K+ATP+CHANNEL | Search K+ATP+CHANNEL |
7 | SULPHONYLUREA RECEPTOR | 36 | 65% | 2% | 34 | Search SULPHONYLUREA+RECEPTOR | Search SULPHONYLUREA+RECEPTOR |
8 | ATP SENSITIVE K CHANNELS | 22 | 33% | 3% | 55 | Search ATP+SENSITIVE+K+CHANNELS | Search ATP+SENSITIVE+K+CHANNELS |
9 | GLIBENCLAMIDE | 21 | 13% | 8% | 158 | Search GLIBENCLAMIDE | Search GLIBENCLAMIDE |
10 | KIR61 | 19 | 60% | 1% | 21 | Search KIR61 | Search KIR61 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SULFONYLUREA RECEPTOR | 355 | 50% | 26% | 508 |
2 | SENSITIVE POTASSIUM CHANNELS | 82 | 20% | 19% | 374 |
3 | ANTIDIABETIC SULFONYLUREAS | 61 | 70% | 3% | 50 |
4 | H 3 GLIBENCLAMIDE | 54 | 80% | 2% | 33 |
5 | DIAZOXIDE | 54 | 30% | 8% | 148 |
6 | GLIBENCLAMIDE BINDING | 50 | 84% | 1% | 27 |
7 | SUR1 | 49 | 66% | 2% | 45 |
8 | OPENERS | 49 | 31% | 7% | 130 |
9 | KIR62 | 48 | 35% | 6% | 111 |
10 | ENERGETIC SIGNALS | 42 | 94% | 1% | 15 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
K-ATP channels as molecular sensors of cellular metabolism | 2006 | 359 | 90 | 64% |
Muscle K-ATP Channels: Recent Insights to Energy Sensing and Myoprotection | 2010 | 76 | 441 | 61% |
Physiological and pathophysiological roles of ATP-sensitive K+ channels | 2003 | 310 | 250 | 60% |
K-ATP Channels and Cardiovascular Disease Suddenly a Syndrome | 2013 | 23 | 168 | 55% |
The role of ATP-sensitive potassium channels in cellular function and protection in the cardiovascular system | 2014 | 4 | 148 | 64% |
A view of SUR/K(IR)6.X, K-ATP channels | 1998 | 384 | 85 | 74% |
ATP-sensitive potassium channelopathies: focus on insulin secretion | 2005 | 220 | 109 | 50% |
SUR1: a unique ATP-binding cassette protein that functions as an ion channel regulator | 2009 | 44 | 76 | 61% |
Sulphonylurea action revisited - the post-cloning era | 2003 | 150 | 154 | 67% |
Treating diabetes today: a matter of selectivity of sulphonylureas | 2012 | 14 | 44 | 52% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHARMACODYNAM THER EUT | 21 | 75% | 0.8% | 15 |
2 | PHARMACODYNAMIE THER EUT | 13 | 61% | 0.7% | 14 |
3 | HENRY WELLCOME GENE FUNCT | 10 | 41% | 1.0% | 19 |
4 | SERV CHIM PHARMACEUT | 8 | 70% | 0.4% | 7 |
5 | CHIM PHARMACEUT | 5 | 20% | 1.3% | 25 |
6 | UNITE CRISTALLOG | 5 | 42% | 0.5% | 10 |
7 | MED CP 617 | 4 | 75% | 0.2% | 3 |
8 | MARRIOTT HEART DIS PROGRAM | 4 | 24% | 0.8% | 15 |
9 | INVEST MEMBRANE EXCITABIL DIS | 2 | 21% | 0.5% | 10 |
10 | BIOMED CLIN | 2 | 44% | 0.2% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000268814 | INTRACELLULAR ION CHANNELS//DIAZOXIDE//5 HYDROXYDECANOATE |
2 | 0.0000232603 | CROMAKALIM//NICORANDIL//LEVCROMAKALIM |
3 | 0.0000159618 | NEONATAL DIABETES MELLITUS//NEONATAL DIABETES//WOLCOTT RALLISON SYNDROME |
4 | 0.0000141948 | CONGENITAL HYPERINSULINISM//NESIDIOBLASTOSIS//HYPERINSULINISM |
5 | 0.0000114602 | GIRK//ANDERSEN TAWIL SYNDROME//KIR21 |
6 | 0.0000094641 | NATEGLINIDE//KAD 1229//REPAGLINIDE |
7 | 0.0000089604 | UNITE ENDOCRINOL METAB//PANCREATIC BETA CELL//INSULIN RELEASE |
8 | 0.0000085491 | ANOXIA AGLYCEMIA//NA CA2 CHANNEL BLOCKER//NS 7 |
9 | 0.0000052559 | GLICLAZIDE//INTERNAL MED DIABETOL CLIN PHARMACOL//DRUG QUAL CONTROL PHARMACOVIGILANC |
10 | 0.0000050903 | PYRAZOLOTHIADIAZINES//HIV 1NNRTIS//ELEMENTORGAN CHEM |